A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS
Status:
Not yet recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study is a Single-arm, Open, Prospective, Single-center, Phase Ⅱ Clinical Study ,Target
population is Advanced Inoperable Resection of Undifferentiated Pleomorphic Sarcoma (UPS) and
Alveolar Soft Tissue Sarcoma (ASPS) .
The purpose of this study was to evaluate the safety and efficacy of combination of
Camrelizumab and Apatinib in the treatment of unresectable UPS and ASPS